The economics are daunting: Rising costs and flat reimbursements mean private groups must work harder to stay independent.
Read More
Zenrelia is one of several drugs Elanco has in its pipeline that it predicts could reach blockbuster status, which in animal health means more than $100 million in annual sales.
Read More
The Carmel medical group is gaining a reputation as a training and education center. It holds courses for high school and college students in anatomy as well as surgeons going out on their own after residencies and fellowships.
Read More
In this week’s edition of the podcast, Schmidt shares his story of recovery from a near fatal injury and how he uses it to help inspire others with mobility issues.
Read More
Wellbridge Surgical is also selling price transparency, with an extensive website that lists prices for more than 250 procedures, ranging from an ear tube removal ($2,610) to a total knee replacement ($23,000).
Britian’s National Institute for Health and Care Excellence said more evidence was needed to prove Kisunla’s worth. Lilly says a year’s worth of treatment is $32,000.
After a racing accident in 2000 left Schmidt a quadriplegic, he created a not-for-profit called Conquer Paralysis Now, which has invested $21.4 million to convert the former Five Seasons Sports Club into a state-of-the-art rehab center.
The Indianapolis company, located in the former St. Bernadette Catholic Church on the near-east side, plans to make the hires by the end of 2025.
The Indianapolis-based health insurer said the name change will better reflect its mission of “elevating whole health and advancing health beyond healthcare.”
Two former employees of Anthem Inc. claim the Indianapolis-based health insurer set work quotas so high that it was impossible to meet them in a 40-hour week, forcing them to work unpaid overtime. Anthem declined to comment.
The companies say they can quickly develop new omicron-targeting antibodies, but those aren’t expected to launch for at least several months.
Marathon Health, which splits its headquarters between Indianapolis and suburban Burlington, Vermont, operates primary-care clinics for employers in 42 states.
Mathilde Merlet oversees one of Eli Lilly and Co.’s fastest-growing products, a medicine called Taltz that treats a variety of dermatology and rheumatology disorders.
Indianapolis-based Apria announced its earnings Tuesday after the markets closed. It marked the company’s first earnings announcement since going public last month.
The aggressive offensive by a Russian-speaking criminal gang coincides with the U.S. presidential election, though there was no immediate indication it was motivated by anything but profit.
The Indiana Donor Network Organ and Tissue Recovery Center has re-tasked two operating rooms and an intensive care unit to recover major organs, such as the kidneys, heart and lungs.
Renaissance Electronic Services, an Indianapolis-based tech company that announced major growth plans in 2016, has been acquired by Atlanta-based Vyne, the companies announced Thursday.
To satisfy House Democrats, the Trump administration removed a provision that would have given the makers of ultra-expensive biologic drugs 10 years of protection from less expensive knockoffs.
Founded in 1983, the practice has 28 physicians and annual revenue of $35 million, and shows little sign of slowing.
The new venture, called MBX Biosciences Inc., aims to develop therapeutics to treat rare endocrine disorders. The company has already raised $2.5 million in funding.
Many of the providers are not traditional health systems, but rather small, for-profit startups attracted by a soaring demand for recovery services.
The drug rebate rule would have ended a widespread practice in which drugmakers give rebates to insurance middlemen in government programs such as Medicare. The idea was to channel that money to consumers instead.
Lilly shares dropped 4.6 percent in early trading after the company said Christi Shaw was leaving and Mike Harrington planned to retire.
MindX founders think they’ve found a scientific way to measure pain and other hard-to-quantify mental health conditions, such as suicide risk, depression and post-traumatic stress disorder.
